GlassScriptPhysician profile
Jeffrey Paul Bacon
NPI 1215910757
$4,673.56
in general payments reported to CMS, 2019-2025
29 companies · $440 in 2025
The $440 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,697 · 2020: $267 · 2021: $260 · 2022: $383 · 2023: $1,016 · 2024: $610 · 2025: $440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,224 · Travel and Lodging: $742 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,224.05 |
| Travel and Lodging | $742.39 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,639.37 | 2019-2025 | Trelegy Ellipta, Nucala, Benlysta |
| Medtronic, INC. | $1,006.32 | 2022-2023 | Illumisite |
| Boston Scientific Corporation | $576.25 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $209.29 | 2019-2025 | Airsupra, Breztri |
| Janssen Pharmaceuticals, INC | $197.47 | 2019-2021 | |
| Allergan, INC. | $173.58 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $162.32 | 2019-2025 | Ofev |
| Harmony Biosciences LLC | $99.99 | 2024 | |
| Sunovion Pharmaceuticals INC. | $61.23 | 2019 | |
| Genentech USA, INC. | $60.77 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $51.56 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $49.77 | 2024-2025 | Glassia |
| Philips North America LLC | $41.85 | 2019 | |
| Pulmonx Corporation | $38.93 | 2024 | Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter |
| Electromed, INC. | $36.24 | 2025 | Smartvest |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $35.67 | 2019-2024 | |
| Astellas Pharma US INC | $29.99 | 2020 | |
| Lilly USA, LLC | $28.29 | 2025 | Zepbound, Mounjaro |
| Insmed, INC. | $21.64 | 2025 | Brinsupri, Arikayce |
| Shire North American Group INC | $20.36 | 2019 | |
| Paratek Pharmaceuticals, INC. | $19.84 | 2025 | Nuzyra |
| Genzyme Corporation | $17.93 | 2019 | |
| Arbor Pharmaceuticals, INC. | $17.61 | 2019 | |
| Verona Pharma, INC. | $17.40 | 2025 | Ohtuvayre |
| Tactile Systems Technology INC | $16.91 | 2025 | Nimbl, Flexitouch Plus |
| Baxter Healthcare | $16.02 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Abbvie INC. | $14.99 | 2023 | Teflaro |
| Veran Medical Technologies, INC. | $7.94 | 2019 | |
| Ceribell, INC. | $4.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Bacon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.